Index of medicine substances

Bifonazole + urea  •  Dermatologicals | Antifungals for topical use | Imidazole and triazole derivatives (D01AC60)

Bilastine  •  Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Other antihistamines for systemic use (R06AX29)

Bimatoprost  •  Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues (S01EE03)

Bimatoprost + timolol  •  Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents (S01ED51)

Bimekizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors (L04AC21)

Binimetinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Mitogen-activated protein kinase (MEK) inhibitors (L01EE03)

Bioactive concentrate from small marine fish  •  Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system (M09AXN2)

Biological (bacterial lysate OM 85 cryodicate)  •  Antiinfectives for systemic use | Other vaccines (J07XN02)

Biological products (bacterial lysates)  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants (L03AXN1)

Biotin  •  Alimentary tract and metabolism | Other plain vitamin preparations (A11HA05)

Biperiden  •  Nervous system | Anticholinergic agents | Tertiary amines (N04AA02)

Birch  •  Dermatologicals | Cicatrizants | Other cicatrizants (D03AX13)

Bisacodyl  •  Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Contact laxatives (A06AB02)

Bismuth oxide  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) (A02BX05)

Bismuth subcitrate  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) (A02BX05)

Bisoprolol  •  Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective (C07AB07)

Bisoprolol + acetylsalicylic acid  •  Cardiovascular system | Beta blocking agents | Beta blocking agents, other combinations (C07FX04)

Bisoprolol + amlodipine  •  Cardiovascular system | Beta blocking agents | Beta blocking agents, other combinations | Beta blocking agents and calcium channel blockers (C07FB07)

Bisoprolol + hydrochlorothiazide  •  Cardiovascular system | Beta blocking agents | Beta blocking agents and thiazides | Beta blocking agents, selective, and thiazides (C07BB07)

Bisoprolol + perindopril  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors, other combinations (C09BX02)

Bivalirudin  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Direct thrombin inhibitors (B01AE06)

Black cohosh rhizome extract  •  Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals (G02CXN3)

Bleomycin sulfate  •  Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Other cytotoxic antibiotics (L01DC01)

Blinatumomab  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Monoclonal antibodies (L01XC19)

Boceprevir  •  Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors (J05AE12)

Bortezomib  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Proteasome inhibitors (L01XG01)

Bosentan  •  Cardiovascular system | Other antihypertensives | Antihypertensives for pulmonary arterial hypertension (C02KX01)

Bosutinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors (L01EA04)

Botulinum antitoxin  •  Antiinfectives for systemic use | Immune sera (J06AA04)

Botulinum toxin type A  •  Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other muscle relaxants, peripherally acting agents (M03AX01)